Abstract-International guidelines recommend that antihypertensive drug therapy should normalize not only diastolic (DBP) but also systolic blood pressure (SBP). Therapeutic trials based on cardiovascular mortality have recently shown that SBP reduction requires normalization of both large artery stiffness and wave reflections. The aim of the present study was to compare the antihypertensive effects of the very-low-dose combination indapamide (0.625 mg) and perindopril (2 mg) (Per/Ind) with the -blocking agent atenolol (50 mg) to determine whether Per/Ind decreases SBP and pulse pressure (PP) more than does atenolol and, if so, whether this decrease is predominantly due to reduction of aortic pulse wave velocity (PWV) (automatic measurements) and reduction of wave reflections (pulse wave analysis, applanation tonometry). In a double-blind randomized study, 471 patients with essential hypertension were followed for 12 months. For the same DBP reduction, Per/Ind decreased brachial SBP (Ϫ6.02 mm Hg; 95% confidence interval, Ϫ8.90 to Ϫ3.14) and PP (Ϫ5.57; 95% confidence interval, Ϫ7.70 to Ϫ3.44) significantly more than did atenolol. This difference was significantly more pronounced for the carotid artery than for the brachial artery. Whereas the 2 antihypertensive agents decreased PWV to a similar degree, only Per/Ind significantly attenuated carotid wave reflections, resulting in a selective decrease in SBP and PP. The very-low-dose combination Per/Ind normalizes SBP, PP, and arterial function to a significantly larger extent than does atenolol, a hemodynamic profile that is known to improve survival in hypertensive populations with high cardiovascular risk. Key Words: antihypertensive therapy Ⅲ pulse wave velocity Ⅲ pulse pressure R ecent epidemiological studies and recommendations of hypertension guidelines 1-3 have directed attention to systolic blood pressure (SBP) as a better guide than DBP for evaluating cardiovascular risk. It has been shown that drug therapy of hypertension frequently results in an adequate control of DBP (Յ90 mm Hg), whereas the ability to control SBP (Յ140 mm Hg) is achieved less often. 4,5 Such results have focused attention on hemodynamic factors, such as large artery stiffness and wave reflections, which are important determinants of SBP and pulse pressure (PP) and are strong independent cardiovascular risk predictors in hypertensive populations. Consequently, the role of drugs or regimens that may selectively reduce SBP and PP assumes importance.Very-low-dose combinations involving an ACE inhibitor (ACEI) and a diuretic (D) may be suitable for reducing SBP and PP and, at the same time, for facilitating the compliance with long-term drug treatment. 2,3,6 -8 In genetic models of hypertension in rats, the ACEI ϩ D combination was shown to induce a significantly more pronounced pressure-independent decrease in arterial stiffness and reduction of aortic collagen accumulation than that of each component given alone. 9,10 In middle-aged patients with hypertension, although D induces only mi...